Dr Canuso is vice president and head of neuropsychiatry clinical development at Johnson & Johnson Innovative Medicine.
New Data on Esketamine Nasal Spray as Treatment for Adolescents Contemplating Suicide
December 12th 2023These important findings on esketamine nasal spray as a treatment for young individuals with suicidal ideation were presented at the ACNP 2023 Annual Meeting. We interviewed the vice president and head of neuropsychiatry clinical development at Johnson & Johnson Innovative Medicine to learn more.